Aster DM Healthcare Ltd
NSE:ASTERDM

Watchlist Manager
Aster DM Healthcare Ltd Logo
Aster DM Healthcare Ltd
NSE:ASTERDM
Watchlist
Price: 554.15 INR -0.7% Market Closed
Market Cap: ₹286.5B

Aster DM Healthcare Ltd
Investor Relations

Aster DM Healthcare Ltd. began its journey in the healthcare sector with a vision to provide accessible and affordable healthcare to communities in the Middle East and India. Founded by Dr. Azad Moopen in 1987, the company has grown into a comprehensive healthcare network boasting hospitals, clinics, and pharmacies across the regions it serves. Aster DM Healthcare operates through its three key verticals: hospitals, clinics, and retail pharmacies. The backbone of their operations lies in integrating these verticals to create a seamless experience for patients, where primary, secondary, and tertiary care effortlessly harmonize. This strategic structure ensures that a patient who visits an Aster clinic for initial consultation can be efficiently referred to one of their hospitals for advanced treatment, if necessary, thereby fostering continuity of care and maintaining patient loyalty within their ecosystem.

The company's revenue streams are diversified across its healthcare offerings. Hospitals serve as the cornerstone, generating revenue through inpatient and outpatient services, specialized medical procedures, and personalized patient care packages. Clinics further complement this by offering outpatient services, routine checkups, and preventive health programs. Then there are the pharmacies, strategically placed to cater to the healthcare needs of patients with a wide array of prescription medications and healthcare products. This integrated business model not only addresses the multifaceted healthcare needs of the community but also creates various touchpoints for revenue generation. With its presence primarily in the GCC (Gulf Cooperation Council) states and India, Aster DM Healthcare leverages its robust network to cater to a substantial market, driven by rising healthcare demands and increasing health awareness among the populace. Through this strategic orchestration of resources and services, the company sustains its growth while maintaining an unwavering focus on quality care.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 2, 2026
AI Summary
Q3 2026

Revenue Growth: The combined Aster DM Healthcare and Quality Care platform grew revenue by 15% year-on-year to INR 2,366 crores, with Aster alone reporting a 13% increase to INR 1,186 crores.

Margin Expansion: Combined operating EBITDA rose 22% YoY to INR 503 crores, with margins at 21%. Quality Care's EBITDA margin expanded 265 bps to 23.7%.

Volume & Case Mix: Patient volumes rose 8-10% YoY across the platform, while richer case mix (CONGO mix and specialty care) and higher ARPP/IP supported growth.

Kerala Cluster Strength: Kerala led performance with 20% revenue growth and strong operating EBITDA margin of 25.4%, buoyed by Medical Value Travel (MVT) and oncology.

Capacity Expansion: Over 560 beds added in the past year, bringing combined capacity to 10,620+ beds, with a pipeline of 4,000 more beds planned.

Merger Progress: The Aster-Quality Care merger has cleared major regulatory hurdles and is expected to close in Q1 FY '27, with integration synergies anticipated.

Synergy Outlook: Management expects 10–15% additional EBITDA from merger synergies over 2–3 years, focusing first on procurement.

Segment Highlights: Diagnostics business turned profitable with 12.2% margins, and losses in wholesale pharmacy were curtailed after strategic exits.

Key Financials
Combined Platform Revenue
INR 2,366 crores
Combined Platform Operating EBITDA
INR 503 crores
Combined Platform Operating EBITDA Margin
21%
Combined Platform ROCE
21%
Aster Revenue from Operations
INR 1,186 crores
Aster Operating EBITDA
INR 224 crores
Aster Operating EBITDA Margin
18.9%
Aster Core Hospitals and Clinics Operating EBITDA Margin
21.4%
Aster Normalized PAT (Excluding Kasaragod & Provisions)
INR 98 crores
Quality Care Revenue
INR 1,181 crores
Quality Care Post-Ind AS EBITDA
INR 279 crores
Quality Care Post-Ind AS EBITDA Margin
23.7%
Quality Care ARPOB
INR 47,000
Quality Care ALOS
3.9 days
Kerala Cluster Revenue
INR 629 crores
Kerala Cluster Operating EBITDA
INR 144 crores
Kerala Cluster Operating EBITDA Margin
25.4%
Aster Labs Revenue
INR 39 crores
Aster Labs EBITDA Margin
12.2% YTD FY '26
Aster Wholesale Pharmacy EBITDA Margin
2.2% (most recent quarter)
Operating Beds (Combined)
10,620+
Pipeline New Beds (Aster DM Healthcare)
2,300+
Quality Care Planned Bed Additions
1,700 beds (next 3–4 years)
Medical Value Travel Revenue Growth (Kerala)
up 64% YoY
Oncology Revenue Growth (Aster)
up 27% YoY
CONGO Mix (Combined Pro Forma)
54.4% (Q3 FY '26)
CONGO-T Share (Quality Care)
57.6%
Cash and Cash Equivalents (Aster)
INR 1,255 crores
Gross Debt (Aster)
INR 631 crores
Other Earnings Calls

Management

Dr. Mandayapurath Azad Moopen DTCD, M.D., MBBS
Founder & Chairman
No Bio Available
Ms. Alisha Moopen
MD, Group CEO & Director
No Bio Available
Mr. Sunil Kumar M. R.
Chief Financial Officer
No Bio Available
Mr. S. Ramesh Kumar
Group Chief Operating Officer
No Bio Available
Mr. Hemish Purushottam
Company Secretary & Compliance Officer
No Bio Available
Mr. Thadathil Joseph Wilson ACA
Group Head of Governance & Corporate Affairs & Executive Director
No Bio Available
Dr. Harsha Rajaram
Chief Executive Officer of Aster Digital Health
No Bio Available
Mr. Veneeth Purushotaman
Group Chief Information Officer
No Bio Available
Mr. Rahul Kadavakolu
Group Chief Marketing Officer
No Bio Available
Dr. Malathi Arshanapalai
Group Chief Medical & Quality Officer
No Bio Available

Contacts

Address
KERALA
DUBAI
33rd Floor, Tower D - Aspect Tower, Executive Tower at Bay Avenuec,Business Bay
Contacts